CUP: B64I17000080001
Ricerca Cardiovascular and sexual/reproductive wellbeing in andro-metabolic disorders: a joint venture between lifestyle and drugs to improve vascular inflammation and oxidative damage (CARDIO-SEX)
SUMMARY OF THE PROJECT
Ricerca Cardiovascular and sexual/reproductive wellbeing in andro-metabolic disorders: a joint venture between lifestyle and drugs to improve vascular inflammation and oxidative damage (CARDIO-SEX)
Implementation indicator
Numero di progetti destinati alle pubbliche amministrazioni o ai servizi pubblici a livello nazionale, regionale o locale
- Target
- 1 num
- Achieved
- 1 num
Download project
Funding monitored
€ 294,160.00
of which cohesion funds
€ 228,528.00
Given name | Amount |
---|---|
Development and Cohesion Fund | 228528.00 |
Another public source | 65632.00 |
Payments monitored
€ 228,528.00
of which cohesion funds
€ 228,528.00
Year | Amount | Cumulative amount | Percentage on public financing |
---|---|---|---|
2019 | 91411.00 | 91411.00 | 31 |
2020 | 68559.00 | 159970.00 | 54 |
2021 | 0 | 159970.00 | 54 |
2022 | 0 | 159970.00 | 54 |
2023 | 68558.00 | 228528.00 | 77 |
State of progress
Open
Expected start: 29/08/2019
Effective start: 29/08/2019
Expected end: 28/08/2023
Effective end: not available
Entities
- Planning body
- MINISTERO DELL'UNIVERSITA' E DELLA RICERCA
- Beneficiary
- UNIVERSITA' DEGLI STUDI DELLA CAMPANIA - 'LUIGI VANVITELLI'
Programming area
- Programme
- PSC MINISTRY UNIVERSITY AND RESEARCH
- 2014-2020 National Development and Cohesion Fund
- 2014-2020 National Development and Cohesion Fund
- Cohesion funds
- € 228,528.00
- Payments on cohesion funds
- € 228,528.00
- Policy Area
- Ricerca e Innovazione
- Sector of intervention
- Ricerca e Sviluppo
Other projects in territory
Same theme
Contratto di sviluppo- Nippon Gases Operations S.r.l. | € 8,967,000 |
Biolife: scienze e biotecnologie per la salute | € 8,061,025 |
POLO DI INNOVAZIONE CYBER BRAIN | € 5,772,550 |
POLO DI INNOVAZIONE CYBER BRAIN | € 3,585,300 |
Sviluppo di Nutraceutici da Fonti Naturali BIONUTRA | € 2,248,403 |